Table of Contents 2
List of Tables 4
List of Figures 4
Orbis Biosciences, Inc. Spshot 5
Orbis Biosciences, Inc. Overview 5
Key Information 5
Key Facts 5
Orbis Biosciences, Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
Orbis Biosciences, Inc. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Orbis Biosciences, Inc. - Pipeline Products Glance 11
Orbis Biosciences, Inc. - Clinical Stage Pipeline Products 11
Phase I Products/Combition Treatment Modalities 11
Orbis Biosciences, Inc. - Early Stage Pipeline Products 12
Preclinical Products/Combition Treatment Modalities 12
Orbis Biosciences, Inc. - Drug Profiles 13
prednisone 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
betamethasone valerate ER 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
bupivacaine hydrochloride ER 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
etonogestrel ER 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
guaifenesin ER 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
meloxicam ER 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
ORB-105 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
ORB-203 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
ritovir 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
tramadol hydrochloride ER 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Orbis Biosciences, Inc. - Pipeline Alysis 23
Orbis Biosciences, Inc. - Pipeline Products by Target 23
Orbis Biosciences, Inc. - Pipeline Products by Route of Administration 24
Orbis Biosciences, Inc. - Pipeline Products by Molecule Type 25
Orbis Biosciences, Inc. - Pipeline Products by Mechanism of Action 26
Orbis Biosciences, Inc. - Locations And Subsidiaries 27
Head Office 27
Appendix 28
Methodology 28
Coverage 28
Secondary Research 28
Primary Research 28
Expert Panel Validation 28
Contact Us 28
Disclaimer 29